Vyxeos liposomal (previously known as Vyxeos) ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vyxeos liposomal (previously known as vyxeos)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - vyxeos liposomal er ætlað fyrir meðferð fullorðnir með nýlega greind, meðferð-tengjast bráð merg hvítblæði (t-aml) eða aml með mergmisþroski-breytingar (aml-yngri og yngri).

Enviage ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskiren - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi.

Riprazo ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

riprazo

novartis europharm ltd. - aliskiren - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi.

Sprimeo ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

sprimeo

novartis europharm ltd. - aliskiren - háþrýstingur - lyf sem hafa áhrif á renín-angíótensín kerfið - meðferð við nauðsynlegum háþrýstingi.

Epidyolex ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

epidyolex

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptics, - epidyolex er ætlað til að nota eins og venjulega meðferð krampa í tengslum við lennox gastaut (lgs) eða dravet heilkenni (ds), með clobazami, fyrir sjúklinga 2 ára og eldri.

Enrylaze ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

enrylaze

jazz pharmaceuticals ireland limited - crisantaspase - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Opzelura ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

opzelura

incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - aðrar húðsjúkdómar - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.

Vedrop ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vedrop

recordati rare diseases - tocofersolan - cholestasis; vitamin e deficiency - vítamín - vedrop er ætlað í d-e skort vegna meltingu vanfrásog í börn sjúklingar sem þjáist af meðfæddri langvarandi gallteppu eða arfgenga langvarandi gallteppu, frá fæðingu (í tíma börn) til 16 eða 18 ára aldri, eftir á svæðinu.

Natpar ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

natpar

takeda pharmaceuticals international ag ireland branch - skjaldkirtilshormón - hypoparateyroidism - kalsíumsterastasis - natpar er ætlað sem viðbótarmeðferð hjá fullorðnum sjúklingum með langvarandi ofsabjúgshjúp, sem ekki er hægt að stjórna með nægilegum hætti með venjulegri meðferð einu sér.